RenovoRx RNXT
NASDAQ RNXT
$1.23 +0.03 (+2.50%)
At close: Oct 21, 2026 · 4:00 PM EDT

RenovoRx (RNXT) EBITDA (2025 - 2026)

Updated

RenovoRx (RNXT) recorded EBITDA of -$3.34 million in Q2 2026, compared with -$1.68 million a year earlier.

Analysis

RenovoRx (RNXT) EBITDA (2025 - 2026) Analysis & Trends

On a TTM basis, RenovoRx's EBITDA came in at -$12.53 million as of Jun 30, 2026; for FY2025, it came in at -$10.51 million.

  • Across earlier years, EBITDA came in at -$10.97 million in FY2024.
  • Quarterly EBITDA has ranged from -$3.52 million in Q4 2025 to -$1.68 million in Q2 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$3.47 million (Q1 2026), -$3.52 million (Q4 2025) and -$2.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn 2.90 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn 2.75 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 1.79 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn 1.19 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn 2.49 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn 1.96 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn 1.53 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn 1.23 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 555.90 Mn
10 RenovoRx 58.89 Mn 19.92 Mn 766,000.00 -3.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.34 Mn
Mar 31, 2026 -3.47 Mn
Dec 31, 2025 -3.52 Mn
Sep 30, 2025 -2.20 Mn
Jun 30, 2025 -1.68 Mn
Mar 31, 2025 -3.11 Mn
API Access

RenovoRx EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=RNXT&period=max&api_key=YOUR_API_KEY